Get a fresh start.
Add this topic to your myFT Digest for news straight to your inbox
Asset managers can learn many lessons from product development in life sciences
Should regulators step in? Time will tell and no doubt there will be some bad actors
Fund companies that fail to address staff worries risk huge outflows